A cancer drug currently in the final stages of clinical trials could offer hope for the treatment of a wide range of inflammatory diseases, including...
Cambridge has been part of a successful £16 million bid to work with the MRC, GSK and four other UK universities in a unique open innovation research...
Inflammation – the body’s response to damaging stimuli – may have a protective effect against cardiovascular disease, according to a study published...